Immunochemistry Reagents, Analysers And Test Kits: World Market 2016-2026

31 August 2016
Pharma

A new report by visiongain estimates that the  Immunochemistry market Report was worth $18.1bn in 2015. These forecasts and others appear in Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests, published in October 2016. Visiongain is a business intelligence company based in London, UK.
The reagents and test kits market is estimated to grow at a CAGR of 7.5% from 2015 to 2020, driven by the rapid tests submarket which is expected to grow at a CAGR of 9.5% from 2015 to 2020.
“The global immunochemistry industry is one of the largest sub- sectors of the global in vitro diagnostics (IVD) market, worth an estimated $18.1bn in 2015. Containing notable submarkets such as disease specific tests, endocrinology test, anaemia/vitamin tests and toxicology testing; this market has benefited from an improvement in both the hardware and software of the industry. Other factors such as the rise of the incidences of cancer, infectious diseases and cardiovascular diseases around the world will continue to fuel demand for better immunochemistry tests in the coming decade; ultimately leading to the emergence of India and China as alternatives to relatively expensive western production. Overall the global immunochemistry industry will progress steadily throughout the forecast period reaching $38.9bn in 2026.”
- Arvind Deol, pharmaceutical market analyst, visiongain, 2016
Visiongain’s new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.
It forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets:

• Immunochemistry reagents and tests kits
• Immunochemistry analysers

The study also forecasts immunochemistry reagents and tests kits subsectors

• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests

This report profiles these leading companies:

• Roche
• Siemens Healthcare
• Abbott
• Danaher
• Ortho Clinical Diagnostics
• bioMérieux

Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests,Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests adds to visiongain’s range of analytical reports on industries and markets in healthcare.

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever